Skip to main content
NVDA-2.15%AAPL+1.33%GOOGL-0.14%MSFT-0.19%AMZN-0.04%TSM-1.84%SPCX+1.81%AVGO-0.20%META-0.07%TSLA-0.22%SKHY-4.72%MU-3.43%BRK-B+0.06%LLY+0.60%JPM-0.43%AMD-2.31%WMT+0.81%V-0.29%XOM-0.46%ASMLa-2.21%JNJ+0.11%INTC-5.28%MA-0.24%0700.HK-1.94%ORCL-2.05%1398.HK+0.79%BAC-0.09%ABBV+0.77%CSCO-0.26%CVX-1.01%COST+0.14%LRCX-3.69%KO+1.14%CAT-0.70%AMAT-1.87%0005.HK-0.78%AP2d-1.11%UNH+0.33%DELL-3.31%HSBA.L-0.98%MS+0.02%PG+0.08%GE+0.44%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.20%HD-0.86%GS-0.13%0939.HK+1.66%NZDJPY-2.67%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.52%GBPJPY-1.47%CADJPY-1.45%EURJPY-1.43%EURNZD+1.28%NZDCAD-1.23%GBPNZD+1.22%NZDUSD-1.18%NZDCHF-1.02%USDNOK+0.96%EURNOK+0.88%CHFNOK+0.85%NOKJPY-0.75%AUDNZD+0.74%USDZAR+0.67%USDSEK+0.61%EURZAR+0.58%USDMXN+0.57%AUDDKK-0.56%AUDCAD-0.54%EURAUD+0.54%EURSEK+0.53%CHFSEK+0.49%GBPZAR+0.49%AUDSGD-0.48%GBPAUD+0.48%AUDUSD-0.45%GBPTRY+0.41%USDTHB+0.38%GBPHKD+0.32%AUDNOK+0.31%NZDSGD-0.29%GBPMXN-0.28%AUDCHF-0.28%USDPLN+0.27%EURCHF+0.24%CADCHF+0.21%GBPCHF+0.20%EURPLN+0.19%USDCHF+0.17%USDSGD+0.17%USDILS+0.16%USDTRY+0.11%EURHKD-0.10%NZDMXN+0.10%USDDKK+0.09%EURSGD+0.08%EURUSD+0.08%PLNJPY-0.06%USDCAD-0.06%GBPUSD+0.05%EURGBP+0.05%EURCZK-0.05%CHFSGD+0.05%SGDJPY+0.05%USDCOP-0.04%USDCNH+0.03%GBPCAD-0.03%EURCNH-0.03%EURCAD+0.02%GBPSGD-0.02%USDHKD0.00%EURDKK0.00%XPTUSD-4.05%HG1-4.03%GAGUSD-3.64%XAGUSD-3.64%UKOIL+1.91%COFFEE-1.84%USOIL+1.73%W1-0.92%COCOA-0.78%GAUUSD-0.64%XAUUSD-0.63%C1-0.56%BTCUSD-1.24%ETHUSD-1.02%USDTUSD-0.06%XRPUSD-1.98%SOLUSD-1.46%TRXUSDT0.00%ZECUSDT-5.46%DOGEUSD-2.43%XMRUSDT-1.64%LINKUSD-0.97%XLMUSD-1.58%BCHUSDT-9.07%LTCUSD-1.45%UNIUSD-3.79%HBARUSDT-1.63%TONUSD+24.88%SUIUSD-2.90%TAOUSDT-4.20%AAVEUSD-2.75%DOTUSDT-3.16%ICPUSDT-0.72%ONDOUSDT-2.53%WLDUSDT-2.43%ATOMUSDT-3.24%ARBUSDT+1.19%JUPUSDT-2.53%INJUSDT-3.51%STXUSDT-3.07%FETUSDT-2.98%TIAUSDT-0.34%PYTHUSDT-0.58%SEIUSDT-3.91%IMXUSDT-3.06%WIFUSDT-3.91%GRTUSDT-2.81%OPUSDT-3.00%IOTAUSDT-3.05%POLUSDT-6.22%AXSUSDT-2.25%FARTCOINUSDT-1.70%EOSUSDT-1.18%DYDXUSDT-0.88%ORDIUSDT-0.21%GALAUSDT-3.65%NOTUSDT-1.83%RONINUSDT-2.64%NVDA-2.15%AAPL+1.33%GOOGL-0.14%MSFT-0.19%AMZN-0.04%TSM-1.84%SPCX+1.81%AVGO-0.20%META-0.07%TSLA-0.22%SKHY-4.72%MU-3.43%BRK-B+0.06%LLY+0.60%JPM-0.43%AMD-2.31%WMT+0.81%V-0.29%XOM-0.46%ASMLa-2.21%JNJ+0.11%INTC-5.28%MA-0.24%0700.HK-1.94%ORCL-2.05%1398.HK+0.79%BAC-0.09%ABBV+0.77%CSCO-0.26%CVX-1.01%COST+0.14%LRCX-3.69%KO+1.14%CAT-0.70%AMAT-1.87%0005.HK-0.78%AP2d-1.11%UNH+0.33%DELL-3.31%HSBA.L-0.98%MS+0.02%PG+0.08%GE+0.44%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.20%HD-0.86%GS-0.13%0939.HK+1.66%NZDJPY-2.67%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.52%GBPJPY-1.47%CADJPY-1.45%EURJPY-1.43%EURNZD+1.28%NZDCAD-1.23%GBPNZD+1.22%NZDUSD-1.18%NZDCHF-1.02%USDNOK+0.96%EURNOK+0.88%CHFNOK+0.85%NOKJPY-0.75%AUDNZD+0.74%USDZAR+0.67%USDSEK+0.61%EURZAR+0.58%USDMXN+0.57%AUDDKK-0.56%AUDCAD-0.54%EURAUD+0.54%EURSEK+0.53%CHFSEK+0.49%GBPZAR+0.49%AUDSGD-0.48%GBPAUD+0.48%AUDUSD-0.45%GBPTRY+0.41%USDTHB+0.38%GBPHKD+0.32%AUDNOK+0.31%NZDSGD-0.29%GBPMXN-0.28%AUDCHF-0.28%USDPLN+0.27%EURCHF+0.24%CADCHF+0.21%GBPCHF+0.20%EURPLN+0.19%USDCHF+0.17%USDSGD+0.17%USDILS+0.16%USDTRY+0.11%EURHKD-0.10%NZDMXN+0.10%USDDKK+0.09%EURSGD+0.08%EURUSD+0.08%PLNJPY-0.06%USDCAD-0.06%GBPUSD+0.05%EURGBP+0.05%EURCZK-0.05%CHFSGD+0.05%SGDJPY+0.05%USDCOP-0.04%USDCNH+0.03%GBPCAD-0.03%EURCNH-0.03%EURCAD+0.02%GBPSGD-0.02%USDHKD0.00%EURDKK0.00%XPTUSD-4.05%HG1-4.03%GAGUSD-3.64%XAGUSD-3.64%UKOIL+1.91%COFFEE-1.84%USOIL+1.73%W1-0.92%COCOA-0.78%GAUUSD-0.64%XAUUSD-0.63%C1-0.56%BTCUSD-1.24%ETHUSD-1.02%USDTUSD-0.06%XRPUSD-1.98%SOLUSD-1.46%TRXUSDT0.00%ZECUSDT-5.46%DOGEUSD-2.43%XMRUSDT-1.64%LINKUSD-0.97%XLMUSD-1.58%BCHUSDT-9.07%LTCUSD-1.45%UNIUSD-3.79%HBARUSDT-1.63%TONUSD+24.88%SUIUSD-2.90%TAOUSDT-4.20%AAVEUSD-2.75%DOTUSDT-3.16%ICPUSDT-0.72%ONDOUSDT-2.53%WLDUSDT-2.43%ATOMUSDT-3.24%ARBUSDT+1.19%JUPUSDT-2.53%INJUSDT-3.51%STXUSDT-3.07%FETUSDT-2.98%TIAUSDT-0.34%PYTHUSDT-0.58%SEIUSDT-3.91%IMXUSDT-3.06%WIFUSDT-3.91%GRTUSDT-2.81%OPUSDT-3.00%IOTAUSDT-3.05%POLUSDT-6.22%AXSUSDT-2.25%FARTCOINUSDT-1.70%EOSUSDT-1.18%DYDXUSDT-0.88%ORDIUSDT-0.21%GALAUSDT-3.65%NOTUSDT-1.83%RONINUSDT-2.64%
PB

Pacific Biosciences of California, Inc. (PACB)

NASDAQ • Healthcare

$1.29
-$0.03 (-2.3%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$1.31
Previous Close$1.29
Day Range$1.26 - $1.34
Avg. Volume (3M)6.6M
Market Cap$400.6M
52 Week Range
$1.07$2.73
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$39M100%
Gross Profitminus cost of goods$12.6M32%

Fundamentals & Financials

Revenue (TTM)
$159.2M
Net Income (TTM)
-$131.3M
EPS (TTM)
-$0.43
ROA (TTM)
-17.48%
Current Ratio
4.92

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+36.8%Q1 2026-$0.12
+82.4%Q2 2026-$0.03
-9.4%Q3 2026-$0.14
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. (NASDAQ: PACB) makes genetic sequencing instruments and related consumables for the medical technology market. Its PacBio Sequencing Systems sit at the center of the business, which generated $160.0 million in FY2025 revenue. The company was founded in 2000 and is based in Menlo Park, California.

Name
Pacific Biosciences of California, Inc.
CEO
Mark Van Oene
Website
www.pacb.com
Industry
Healthcare
Year Founded
2000
Employees
485

Today's Snapshot

AI-generated

PACB ended yesterday 2.3% down at 1.29. Pacific Biosciences launched Vega SPRQ-Nx, a sequencing chemistry that delivers 50% more HiFi data.

Trading Volume

Below 10d avg (5.4M)

4.1M

vs S&P 500 Today

Underperforming Market

-1.79%

Updated: September 10, 2026 at 12:07 UTC

PACB Headlines

Healthcare stocks fall after weak US jobs data

March 6, 2026

3 min read
View All News

Technical Indicators

0 Buy2 Neutral6 Sell
PACB is trading beneath virtually all measured moving averages, including the 200-day, and that pervasive weakness is reinforced by negative momentum and a selling MACD. Trend strength is muted with a low ADX just under 15, but volume metrics are strongly negative as on-balance volume shows significant outflows. Volatility is elevated with an ATR around 7.6% of price, so downside swings have been pronounced. Taken together, price structure, momentum and volume favor a sharply bearish technical profile. Technical takeaway: Strong Sell.
All signals
  • EMA (5 indicators)$1.33 - $1.56
    Sell
  • RSI (14)46.97
    Neutral
  • Stochastic %K (14, 3, 3)31.39
    Neutral
  • MACD Level (12, 26)-0.00
    Sell

Peers & Related Assets

IOVAIovance Biotherapeutics, Inc.
$8.43-3.1%
BFLYButterfly Network, Inc.
$7.46-0.8%
IARTIntegra LifeSciences Holdings Corporation
$16.25-0.1%
SIBNSI-BONE, Inc.
$18.41-1.1%
FLGTFulgent Genetics, Inc.
$19.85-1.7%
OFIXOrthofix Medical Inc.
$8.91-2.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.